Leap Therapeutics (LPTX) Short Interest Ratio & Short Volume → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free LPTX Stock Alerts $3.19 +0.02 (+0.63%) (As of 05/3/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Leap Therapeutics Short Interest DataCurrent Short Volume1,450,000 sharesPrevious Short Volume1,140,000 sharesChange Vs. Previous Month+27.19%Dollar Volume Sold Short$4.35 millionShort Interest Ratio / Days to Cover4.5Last Record DateApril 15, 2024Outstanding Shares25,600,000 sharesFloat Size23,430,000 sharesShort Percent of Float6.19%Today's Trading Volume334,593 sharesAverage Trading Volume553,266 sharesToday's Volume Vs. Average60% Short Selling Leap Therapeutics ? Sign up to receive the latest short interest report for Leap Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatLPTX Short Interest Over TimeLPTX Days to Cover Over TimeLPTX Percentage of Float Shorted Over Time Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. Leap Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20241,450,000 shares $4.35 million +27.2%6.2%4.5 $3.00 3/31/20241,140,000 shares $3.03 million +0.9%4.9%4.7 $2.66 3/15/20241,130,000 shares $2.50 million -3.4%4.8%4.4 $2.21 2/29/20241,170,000 shares $3.26 million +4.5%5.0%4.4 $2.79 2/15/20241,120,000 shares $3.66 million +74.8%4.8%4 $3.27 1/31/2024640,800 shares $1.92 million +7.3%2.7%2.2 $3.00 Get the Latest News and Ratings for LPTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Leap Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024597,400 shares $2.10 million +5.3%2.5%2.3 $3.51 12/31/2023567,300 shares $2.35 million +2.9%2.4%2.4 $4.15 12/15/2023551,200 shares $1.67 million -2.2%2.4%1.8 $3.03 11/30/2023563,600 shares $1.27 million -29.4%2.4%2 $2.25 11/15/2023798,100 shares $1.28 million +7.2%3.4%2.9 $1.60 10/31/2023744,200 shares $1.09 million +24.6%3.2%3.1 $1.47 10/15/2023597,500 shares $908,200.00 -15.1%2.5%2 $1.52 9/30/2023703,400 shares $970,692.00 +2.7%3.0%2.1 $1.38 9/15/2023684,800 shares $1.08 million +1.9%2.9%2.7 $1.57 8/31/2023671,800 shares $1.50 million -3.2%3.2%2.6 $2.23 8/15/2023694,300 shares $1.76 million -5.3%3.3%2.7 $2.54 7/31/2023732,800 shares $2.01 million -36.3%7.5%2.9 $2.74 7/15/20231,150,000 shares $3.62 million +3.6%12.0%6.4 $3.15 6/30/20231,110,000 shares $3.47 million +6.7%11.6%7.9 $3.13 6/15/20231,040,000 shares $6.29 million -89.8%10.8%8.6 $6.05 5/31/202310,230,000 shares $9.10 million -11.2%N/A10.5 $0.89 5/15/202311,520,000 shares $5.18 million +0.1%N/A14.7 $0.45 4/30/202311,510,000 shares $4.50 million No ChangeN/A19.4 $0.39 4/15/202311,510,000 shares $4.52 million +1.1%N/A16.3 $0.39 3/31/202311,390,000 shares $3.87 million +20.0%N/A15.8 $0.34 3/15/20239,490,000 shares $3.92 million +5.8%N/A12.2 $0.41 2/28/20238,970,000 shares $5.11 million +45.2%N/A12.3 $0.57 2/15/20236,180,000 shares $3.72 million +22.1%N/A8.5 $0.60 1/31/20235,060,000 shares $3.36 million +15.0%N/A6.2 $0.67 1/15/20234,400,000 shares $2.56 million +57.1%N/A5.5 $0.58 12/30/20222,800,000 shares $1.26 million +27.3%N/A4.6 $0.45 12/15/20222,200,000 shares $1.10 million -1.4%N/A3.9 $0.50 11/30/20222,230,000 shares $1.35 million -6.3%N/A3.6 $0.60 11/15/20222,380,000 shares $1.67 million -32.6%N/A3.5 $0.70 10/31/20223,530,000 shares $3.00 million +10.3%N/A5.1 $0.85 10/15/20223,200,000 shares $2.82 million +10.7%N/A5.3 $0.88 9/30/20222,890,000 shares $2.54 million +10.7%N/A4.7 $0.88 9/15/20222,610,000 shares $3.08 million No ChangeN/A3.9 $1.18 8/31/20222,610,000 shares $3.71 million +6.5%N/A4.1 $1.42Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. LPTX Short Interest - Frequently Asked Questions What is Leap Therapeutics' current short interest? Short interest is the volume of Leap Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 1,450,000 shares of LPTX short. 6.19% of Leap Therapeutics' shares are currently sold short. Learn More on Leap Therapeutics' current short interest. What is a good short interest ratio for Leap Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LPTX shares currently have a short interest ratio of 4.0. Learn More on Leap Therapeutics's short interest ratio. What is a good short interest percentage for Leap Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.19% of Leap Therapeutics' floating shares are currently sold short. Is Leap Therapeutics' short interest increasing or decreasing? Leap Therapeutics saw a increase in short interest in April. As of April 15th, there was short interest totaling 1,450,000 shares, an increase of 27.2% from the previous total of 1,140,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Leap Therapeutics' float size? Leap Therapeutics currently has issued a total of 25,600,000 shares. Some of Leap Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Leap Therapeutics currently has a public float of 23,430,000 shares. How does Leap Therapeutics' short interest compare to its competitors? 6.19% of Leap Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Leap Therapeutics: Barinthus Biotherapeutics plc (0.04%), LifeVantage Co. (0.66%), BeyondSpring Inc. (10.07%), InflaRx (0.22%), Marinus Pharmaceuticals, Inc. (8.23%), Affimed (1.66%), Aileron Therapeutics, Inc. (0.31%), Tempest Therapeutics, Inc. (6.74%), Connect Biopharma Holdings Limited (0.16%), Spero Therapeutics, Inc. (0.95%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Leap Therapeutics stock? Short selling LPTX is an investing strategy that aims to generate trading profit from Leap Therapeutics as its price is falling. LPTX shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Leap Therapeutics? A short squeeze for Leap Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LPTX, which in turn drives the price of the stock up even further. How often is Leap Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LPTX, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Barinthus Biotherapeutics Short Interest LifeVantage Short Interest BeyondSpring Short Interest InflaRx Short Interest Marinus Pharmaceuticals Short Interest Affimed Short Interest Aileron Therapeutics Short Interest Tempest Therapeutics Short Interest Connect Biopharma Short Interest Spero Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LPTX) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe only AI company you should be looking atBehind the MarketsThe A.I. story nobody is telling you (Read ASAP)TradeSmith